Keywords: bioenvision, initiates, clofarabine, clinical, development, program, usa-based

Bioenvision initiates clofarabine clinical development program

Article | 15 July 2002

USA-based Bioenvision has initiated a clinical development program forits second-generation nucleoside analog Clofarex (clofarabine). The company plans to conduct Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Clofarabine

Clolar

Go to drug listing